4/21/2014 1:00:00 AM
KineMed, Inc. announced participation in a global, two year, multi-organization effort to advance and standardize a single mouse model of early diabetic disease detection and progression. The two year effort brings together cutting edge expertise and technology with a goal to produce a new mouse research model system that can streamline the research and development of advances in diabetic research and improve the clinical success of programs using the model.
4/4/2014 1:00:00 AM
KineMed, Inc. announced today that Dr. Marc Hellerstein, KineMed’s President and CSO, will give an invited presentation titled “Quantifying in vivo metabolic pathway fluxes and network dynamics using heavy water and mass spectrometry: A new class of disease biomarkers” at the American Association for Cancer Research Annual Meeting, taking place April 5-9, in San Diego, California.
3/20/2014 1:00:00 AM
KineMed, Inc. announced today that abstracts were accepted for three oral and four poster presentations highlighting its work in liver fibrosis at the Keystone Fibrosis Symposium taking place March 23–28, 2014 in Keystone, Colorado. Dr. Scott Turner, KineMed’s Executive Vice President of Research, Dr. Claire Emson, KineMed’s Director of Fibrosis Research, and Dr. Martin Decaris, postdoctoral researcher in Cellular and Molecular Kinetics at KineMed, will represent KineMed at the conference.
Marc Hellerstein, M.D., Ph.D., President and Chief Scientific Officer
talks about the power of Proteome Dynamics at the Personalized Medicine World Conference